HY25 operating cash burn widened 72% while revenue reverted to zero

What changed

• Revenue fell from $0.4k in HY24 to $0 in HY25, so the group is effectively back to pre-revenue status after booking a token top line a year ago.
• Net loss widened 40.6% to $0.9m (HY24: $0.7m), driven by below-operating items rather than tax, since no tax charge was recorded in either period.
• Operating cash outflow deteriorated 71.8% to $0.9m (HY24: $0.5m), and with $0.5m of plant and equipment spend, pre-lease free cash outflow reached about $1.4m.
• Cash on hand rose 25.0% to $1.2m despite the wider burn, funded by financing activity that also cut gross borrowings from $1.0m to $0.2m as the convertible note was largely converted.
• Total liabilities fell 42.1% to $0.8m while equity rose 4.4% to $10.0m, shifting the group from roughly $33k of net debt to a net cash position of approximately $1.0m.

What matters

• The cash burn rate is accelerating faster than revenue is arriving. Operating outflow plus capex of roughly $1.4m against a year-end cash balance of $1.2m means the current cash stack does not, on its own, fund another comparable half at this spend intensity.
• The balance sheet has been cleaned up through convertible note conversion and share issuance. That removes a near-term refinancing risk and is the most concrete positive in the release, but it also implies dilution that the extraction materials do not quantify.
• There is no quantified production or revenue target in the release. References to an "agreement and forward workplan", a purchased processing plant, and Mystery vein South indicate ongoing development, but none of this is translated into a dated or dollar-denominated milestone.

Expectations

FY24 shape is heavily second-half weighted: $43.0m of reported full-year revenue against $0.4k in HY24, so the second half carried essentially all of it. HY25 has reset back to zero, so annualising the current half produces no revenue versus that $43.0m FY24 anchor. The release does not restate or reaffirm the FY24 revenue run-rate, so the read-through is that either FY24 contained a one-off recognition event or second-half HY25 must do disproportionate work to match last year. No quantified guidance or target was disclosed in the extracted materials, so this briefing cannot benchmark the half against a company-supplied trajectory.

Quality of result

• The widening of the loss is operating, not tax-driven: the PBT/NPAT gap is zero and effective tax is zero in both periods, so the deterioration reflects real spend rather than a tax normalisation.
• Cash conversion deteriorated materially: operating cash outflow exceeded the net loss by roughly 92%, meaning working-capital and non-cash items worked against, rather than for, the reported earnings line. Receivables, inventory and payables were not disclosed in sufficient detail to isolate the driver.
• The improvement in the net cash position is financing-assisted, not operating. It reflects convertible conversion and new issuance rather than internally generated funds, and should not be read as evidence that the underlying business is self-sustaining.

Unresolved

• The extraction does not disclose the quantum of shares issued on conversion, the strike of any new capital raised, or the resulting share count, so per-share dilution cannot be assessed.
• There is no disclosed breakdown of the components driving the widening operating outflow, no working-capital movement schedule, and no restated inventory balance at period end.
• The FY24 $43.0m revenue figure is not reconciled or explained in the HY25 extracts, leaving open whether it represents recurring production, one-off recognition, or a different accounting treatment.
• No forward-work value, backlog, or stated production-start date accompanies the references to NZPAM approvals and the Mystery vein South plan.
• This briefing cannot assess dilution, funding runway beyond the current half, or the commercial substance of the FY24 revenue base, because the underlying disclosures are not present in the extracted materials.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.